 
                        | Product NDC: | 0378-4298 | 
| Proprietary Name: | Minocycline Hydrochloride | 
| Non Proprietary Name: | minocycline hydrochloride | 
| Active Ingredient(s): | 135 mg/1 & nbsp; minocycline hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0378-4298 | 
| Labeler Name: | Mylan Pharmaceuticals Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA090911 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120829 | 
| Package NDC: | 0378-4298-93 | 
| Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4298-93) | 
| NDC Code | 0378-4298-93 | 
| Proprietary Name | Minocycline Hydrochloride | 
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4298-93) | 
| Product NDC | 0378-4298 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | minocycline hydrochloride | 
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20120829 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Mylan Pharmaceuticals Inc. | 
| Substance Name | MINOCYCLINE HYDROCHLORIDE | 
| Strength Number | 135 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |